Quantcast

Latest dizziness Stories

2011-03-03 16:29:00

PITTSBURGH, March 3, 2011 /PRNewswire/ -- Neuro Kinetics, Inc. (NKI) (www.neuro-kinetics.com), manufacturers of noninvasive medical diagnostic equipment used worldwide to test for vestibular and neurological conditions, said today that it co-presented two research studies at this week's American Balance Society conference meeting in Scottsdale, Arizona. The research continues the company's push to expand and refine the clinical testing that can be conducted with its medical equipment in...

2011-01-12 11:15:00

ATLANTA, Jan. 12, 2011 /PRNewswire/ -- Comprehensive analyses of pooled data from three randomized, double-blind, placebo-controlled Phase II/III trials showing the efficacy and tolerability of Vimpat® (lacosamide) C-V for patients with partial-onset seizures, regardless of the type of concomitant AED used, have been published in the drug evaluation journal, CNS Drugs(1,2). Two key papers have reported that adjunctive lacosamide reduced seizures and improved responder...

2010-12-06 11:00:00

ATLANTA, Dec. 6, 2010 /PRNewswire/ -- UCB today announced new findings for Vimpat® (lacosamide) C-V that offer additional support regarding the long-term benefits of the antiepileptic drug (AED) as an adjunctive therapy for adults with uncontrolled partial-onset seizures. To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/vimpat/34012/ "These data add to the growing body of support showing that...

2010-09-30 11:00:00

BRUSSELS, Sept. 30 /PRNewswire/ -- People with Parkinson's disease who used once-daily Neupro® (rotigotine) in the RECOVER trial achieved improvements in quality of life, in addition to previously reported beneficial effects on motor and non-motor symptoms. Data presented this week at the 2nd World Parkinson Congress in Glasgow, UK, showed that Neupro® provided clinically relevant improvements in PDQ-8 score. This is a self-administered health-related...

2010-08-30 14:37:00

RARITAN, N.J., Aug. 30 /PRNewswire/ -- Phase 3 safety and efficacy data comparing tapentadol extended release (ER) tablets, an investigational pain medication, to placebo in patients with moderate to severe chronic osteoarthritis knee pain have been published by Clinical Drug Investigation. In addition, this study compared oxycodone controlled release (CR) to placebo as an active control. Tapentadol ER vs. Placebo The study demonstrated that a significantly higher percentage of patients...

2010-06-29 06:30:00

ATLANTA, June 29 /PRNewswire/ -- New long term data showed that Vimpat® (lacosamide) C-V provided sustained reduction in seizure frequency for up to five years when used as an add-on treatment for uncontrolled partial onset seizures in adults with epilepsy. In addition post-hoc exploratory analyses showed that adjunctive lacosamide treatment reduced partial-onset seizure frequency and improved responder rates when added to a broad range of antiepileptic drugs (AEDs)...

2010-06-17 07:30:00

BRUSSELS, June 17 /PRNewswire-FirstCall/ -- New data presented this week at the 14th International Congress of Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina (June 13-17, 2010) showed that Neupro® (rotigotine transdermal system) provided significantly greater improvement in early morning motor symptoms and sleep quality, compared with placebo, and as measured by the Unified Parkinson's Disease Rating Scale and the Parkinson's Disease Sleep Scale....

2010-06-04 13:09:00

Prismatic eyeglass lenses resulted in 71.8 percent reduction of symptoms ANN ARBOR, Mich., June 4 /PRNewswire-USNewswire/ -- A recent retrospective study by four Michigan physicians shows strong evidence that symptoms of headache, dizziness and anxiety in some patients with traumatic brain injury potentially could be alleviated or even eliminated with specialized eyeglass lenses containing prisms. The paper was published in the April 2010 issue of Physical Medicine and Rehabilitation....

2010-04-14 07:30:00

ATLANTA, April 14 /PRNewswire/ -- Evidence of Neupro® (Rotigotine Transdermal System) improving motor as well as non-motor symptoms of Parkinson's disease was presented at the 62nd American Academy of Neurology annual meeting in Toronto, Canada. "The new data reported this week showed that treatment with rotigotine controlled early morning motor function and improved non-motor symptoms, as judged by the validated non-motor scale, in patients with Parkinson's disease...

2010-02-03 07:00:00

INDIANAPOLIS, Feb. 3 /PRNewswire-FirstCall/ -- In a new study, 60 mg of Cymbalta® (duloxetine HCl) taken once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory (BPI) average pain rating, compared with placebo.(1) The data were presented today at the annual meeting of the American Academy of Pain Medicine (AAPM) in San Antonio, Texas. A total of 401 patients participated in the 12-week, double-blind, placebo-controlled study,...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related